Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin

Clinical and Experimental Immunology

Volumn 147, Issue 1, 2007, Pages 176-183

  Sugita, K ^a   Kabashima, K ^a   Atarashi, K ^a   Shimauchi, T ^a   Kobayashi, M ^a   Tokura, Y ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Antigen presentation; Keratinocytes; Langerhans cell; Toll like receptor

Indexed keywords

CD86 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HAPTEN; INTERLEUKIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR 9; TRINITROPHENYLHAPTEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; EPIDERMIS CELL; FEMALE; FLOW CYTOMETRY; IMMUNE SYSTEM; INNATE IMMUNITY; KERATINOCYTE; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, CD86; CELLS, CULTURED; CPG ISLANDS; CYTOKINES; FEMALE; HAPTENS; IMMUNITY, ACTIVE; IMMUNITY, NATURAL; KERATINOCYTES; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PICRYL CHLORIDE; SKIN; SKIN DISEASES; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9;

EID: 33845475904     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03258.x     Document Type: Article

References (25)

1. Medzhitov R, Janeway CA. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997; 9:4-9.
2. Lemaitre B, Nicolas E, Michaut L et al. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996; 86:973-83.
3. Takeda K, Akira S. Microbial recognition by Toll-like receptors. J Dermatol Sci 2004; 34:73-82.
4. Kawai K, Shimura H, Minagawa M et al. Expression of functional Toll-like receptor 2 on human epidermal keratinocytes. J Dermatol Sci 2002; 30:185-94.
5. Miller LS, Sorensen OE, Liu PTD et al. TGF-α regulates TLR expression and function on epidermal keratinocytes. J Immunol 2005; 174:6137-43.
6. Mitsui H, Watanabe T, Saeki H et al. Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. J Invest Dermatol 2004; 122:95-102.
7. Matsushima H, Yamada N, Matsue H et al. TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 2004; 173:531-41.
8. Takeuchi J, Watari E, Shinya E et al. Down-regulation of Toll-like receptor expression in monocyte derived Langerhans cell-like cells: implication of low responsiveness to bacterial components in the epidermal Langerhans cells. Biochem Biophys Res Commun 2003; 306:674-9.
9. Nickoloff BJ, Turka LA, Mitra RS et al. Direct and indirect control of T-cell activation by keratinocytes. J Invest Dermatol 1995; 105:25S-9S.
10. Tokura Y, Yagi J, O'Malley M et al. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J Invest Dermatol 1994; 102:31-8.
11. Tokura Y, Yagi H, Hashizume H, Yagi J et al. Accessory cell ability of Langerhans cells for superantigen is resistant to ultraviolet-B light. Photochem Photobiol 1994; 60:147-53.
12. Latz E, Schoenemeyer A, Visintin A et al. TLR9 signals after translocating from ER to CpG DNA in the lysosome. Nat Immunol 2005; 5:190-8.
13. Mempel M, Voelcker V, Kollisch G et al. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 2003; 121:1389-96.
14. Strober W. Epithelial cells pay a Toll for protection. Nat Med 2004; 10:898-900.
15. Singh JC, Cruickshank SM, Newton DJ et al. Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis. Am J Physiol Gastrointest Liver Physiol 2005; 288:514-24.
16. Schaefer TM, Desouza K, Fahey JV et al. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 2004; 112:428-36.
17. Witmer-Pack MD, Olivier W, Valinsky J et al. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 1987; 166:1484-98.
18. Koch F, Heufler C, Kampgen E et al. Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation. J Exp Med 1990; 171:159-71.
19. Heufler C, Koch F, Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 1998; 167:700-5.
20. Inaba K, Witmer-Pack M, Inaba M et al. The tissue distribution of the B7-2 co-stimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 1994; 180:1849-60.
21. Enk AH, Angeloni VL, Udey MC et al. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J Immunol 1993; 150:3698-704.
22. Ozawa H, Nakagawa S, Tagami H et al. Interleukin-1 beta and granulocyte-macrophage colony stimulating factor mediate Langerhans cell maturation differently. J Invest Dermatol 1996; 106:441-5.
23. Nishijima T, Tokura Y, Imokawa G et al. Photohapten TCSA painting plus UVA irradiation of murine skin augments the expression of MHC class II molecules and CD86 on Langerhans cells. J Dermatol Sci 1999; 19:202-7.
24. McInturff JE, Modlin RL, Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 2005; 125:1-8.
25. Braff MH, Bardan A, Nizet V et al. Cutaneous defense mechanism by antimicobial peptides. J Invest Dermatol 2005; 125:9-13.